Treatment of Xerostomia with the Bile Secretion-Stimulating Drug Anethole Trithione: A Clinical Trial
- 1 September 1999
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 318 (3) , 146-151
- https://doi.org/10.1097/00000441-199909000-00009
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Drug-induced mouth disordersClinical and Experimental Dermatology, 1995
- Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatmentInternational Journal of Oral & Maxillofacial Surgery, 1990
- Clinical oral test for the assessment of oral symptoms of glossodynia and glossopyrosisJournal of Oral Rehabilitation, 1990
- Enhancement of Phosphatidylinositol Turnover and Cyclic Nucleotide Accumulation by Chronic Anethole Trithione Treatment in Rat Submaxillary GlandsJournal of Pharmacy and Pharmacology, 1989
- Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunctionOral Surgery, Oral Medicine, Oral Pathology, 1988
- Prospective study of aetiological factors in burning mouth syndromeBMJ, 1988
- Identification of Cellular Activation Mechanisms Associated with Salivary SecretionAnnual Review of Physiology, 1986
- Metabolism of inositol phosphates in parotid cells: Implications for the pathway of the phosphoinositide effect and for the possible messenger role of inositol trisphosphateLife Sciences, 1984
- Role of salivary mucins in the protection of the oral cavityJournal of Oral Pathology & Medicine, 1982
- Clinical trials of a sialogogue in humans: a preliminary reportSpecial Care in Dentistry, 1982